Strategic Milestone in Europe! Novo Nordisk Introduces the Weight Loss Pill to Great Britain!
Reading Time: 3 minutes
Approval Success: Great Britain becomes the first European country to approve the Wegovy pill for daily use in obesity Market Potential: An online pharmacy already reports over 10,000 pre-orders, 75% of which are new patients with no injection history Security Risk: At the same time, Novo Nordisk reports an IT incident involving unauthorized access to non-public and personal data The Danish pharmaceutical company Novo Nordisk (NVO) has achieved a regulatory milestone in the European market. The British regulatory authority MHRA has approved...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
